Literature DB >> 19447933

Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome.

Annelies Boonen1, Bert vander Cruyssen, Kurt de Vlam, Serge Steinfeld, Clio Ribbens, Jan Lenaerts, Filip Van den Bosch, Herman Mielants, Lode Dewulf, Nathan Vastesaeger.   

Abstract

OBJECTIVE: To determine which patients with ankylosing spondylitis (AS) have radiographic spinal damage and to investigate the relation between radiographic spinal changes and limitations in physical function.
METHODS: A cross-sectional nationwide study in Belgium of patients with AS under the care of a rheumatologist. The treating physician completed a questionnaire including clinical disease manifestations and laboratory findings (HLA-B27 and C-reactive protein), and classified spinal radiographs into 3 categories: (1) no AS-related spinal abnormalities; (2) syndesmophytes; and (3) spinal ankylosis. Patients completed the Bath AS Disease Activity Index (BASDAI) and the Bath AS Functional Index (BASFI). Ordinal regressions were performed to quantify the relationship between clinical manifestations and spinal radiographic changes. Generalized linear models were computed to quantify relationships among clinical manifestations, radiographic spinal changes, and functioning (BASFI).
RESULTS: A total of 619 patients fulfilled modified New York criteria for definite AS and had evaluable radiographic data; 68% were male and disease duration was 17.5 (SD 12.2) years. Male sex, younger age at symptom onset, and hip involvement were associated with radiographic changes; but HLA-B27, peripheral arthritis, and extraarticular disease status (uveitis, psoriasis, and inflammatory bowel disease) were not. Older age, BASDAI, hip involvement, and spinal change contributed to BASFI; but sex, disease duration, peripheral arthritis, and extraarticular manifestations did not.
CONCLUSION: Radiographic spinal changes in patients with AS are seen more often in men and those with hip involvement. BASFI status indicates the influence of radiographic changes and hip involvement, but does not reflect the presence of peripheral arthritis and does not differ between men and women.

Entities:  

Mesh:

Year:  2009        PMID: 19447933     DOI: 10.3899/jrheum.080831

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  19 in total

1.  Dynamics of syndesmophyte growth in AS as measured by quantitative CT: heterogeneity within and among vertebral disc spaces.

Authors:  Sovira Tan; Jianhua Yao; John A Flynn; Lawrence Yao; Michael M Ward
Journal:  Rheumatology (Oxford)       Date:  2014-11-12       Impact factor: 7.580

2.  [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 3 Clinical symptoms].

Authors:  U Kiltz; M Rudwaleit; J Sieper; D Krause; J-F Chenot; A Stallmach; S Jaresch; U Oberschelp; E Schneider; B Swoboda; H Böhm; A Heiligenhaus; U Pleyer; W-H Böhncke; M Stemmer; J Braun
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

3.  Spinal mobility and its impact in Moroccan patients with ankylosing spondylitis.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Redouane Abouqal; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2010-11-06       Impact factor: 2.980

4.  Spondyloarthritis in a pediatric population: risk factors for sacroiliitis.

Authors:  Matthew L Stoll; Rafia Bhore; Molly Dempsey-Robertson; Marilynn Punaro
Journal:  J Rheumatol       Date:  2010-08-03       Impact factor: 4.666

5.  Correlation between clinical and MRI disease activity scores in axial spondyloarthritis.

Authors:  James W MacKay; Sharief Aboelmagd; J Karl Gaffney
Journal:  Clin Rheumatol       Date:  2015-04-19       Impact factor: 2.980

6.  Functional limitation and associated factors in outpatients with ankylosing spondylitis in Southwest China.

Authors:  Yuqing Song; Chen Wang; Hong Chen
Journal:  Clin Rheumatol       Date:  2017-02-06       Impact factor: 2.980

7.  Functional limitations due to axial and peripheral joint impairments in patients with ankylosing spondylitis: are focused measures more informative?

Authors:  Siddharth Bethi; Abhijit Dasgupta; Michael H Weisman; Thomas J Learch; Lianne S Gensler; John C Davis; John D Reveille; Michael M Ward
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-04       Impact factor: 4.794

8.  Regional radiographic damage and functional limitations in patients with ankylosing spondylitis: differences in early and late disease.

Authors:  Michael M Ward; Thomas J Learch; Lianne S Gensler; John C Davis; John D Reveille; Michael H Weisman
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-02       Impact factor: 4.794

9.  Absence of radiographic progression of hip arthritis during infliximab treatment for ankylosing spondylitis.

Authors:  M Konsta; P P Sfikakis; V K Bournia; D Karras; A Iliopoulos
Journal:  Clin Rheumatol       Date:  2013-04-21       Impact factor: 2.980

10.  The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis.

Authors:  Nigil Haroon; Robert D Inman; Thomas J Learch; Michael H Weisman; MinJae Lee; Mohammad H Rahbar; Michael M Ward; John D Reveille; Lianne S Gensler
Journal:  Arthritis Rheum       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.